用生理学基础的药理动力学建模优化剂量用于患有脏功能障碍的儿科患者:梅罗尼姆的案例研究
Najia Rahim1, Muhammad Sarfraz2, Abubakar Bello3
1Department of Pharmacy Practice, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan. najia.rahim@duhs.edu.pk.
AAPS PharmSciTech
|January 17, 2025
概括
这项研究开发了一种基于生理学上的药理动力学 (PBPK) 模型,用于治疗儿科患者的梅罗. 该模型优化了美罗胺的剂量,为中度和严重的RI推降低剂量,以确保有效的血度.
科学领域:
- 药理动力学和药物新陈代谢
- 儿科脏病学 儿科脏病学
- 计算药理学计算药理学
背景情况:
- 通过脏排出的抗生素的药理动力学受到儿科患者功能变化的影响.
- 在患有功能不全的儿科患者中,关于美罗的药理动力学数据有限.
研究的目的:
- 开发一个基于生理学的药理动力学 (PBPK) 模型,用于儿科患者的美罗.
- 在患有功能障碍 (RI) 的儿科患者中优化美罗胺剂量.
主要方法:
- 使用GastroPlusTM 9.9与文献数据开发了一个PBPK模型.
- 该模型被扩展到患有不同程度的RI的儿科患者.
- 使用AUC和Cmax的平均折叠误差 (AFE) 来评估模型的合适性.
主要成果:
- 对AUC0-t,AUC0-α和Cmax的AFE值分别为1.60,1.08和1.48.
- 建议在中度RI时将美罗胺剂量降至10mg/kg,在严重RI时降至7.5mg/kg.
- 在 RI.虚拟儿科群体中,优化剂量达到最低抑制度 (MIC) 以上的目标时间.
结论:
- 开发的PBPK模型量化评估了RI对儿科梅罗胺药理动学的影响.
- 这种工具有助于优化儿科患者的梅罗胺剂量方案.
相关概念视频
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Pharmacokinetic Models: Overview
573
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
573
Renal Failure: Dose Adjustments
61
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
61
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
26
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
26
Pharmacokinetic Models: Comparison and Selection Criterion
38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
78
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
78


